Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Tax Provisions (2022 - 2024)

Beam Therapeutics (BEAM) has disclosed Tax Provisions for 3 consecutive years, with $39000.0 as the latest value for Q2 2024.

  • Quarterly Tax Provisions changed N/A to $39000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $39000.0 through Mar 2025, down 97.21% year-over-year, with the annual reading at $39000.0 for FY2024, 97.21% down from the prior year.
  • Tax Provisions for Q2 2024 was $39000.0 at Beam Therapeutics, down from $1.4 million in the prior quarter.
  • The five-year high for Tax Provisions was $2.4 million in Q3 2022, with the low at $39000.0 in Q2 2024.
  • Average Tax Provisions over 3 years is $1.2 million, with a median of $1.2 million recorded in 2022.
  • Peak annual rise in Tax Provisions hit 41.41% in 2023, while the deepest fall reached 41.41% in 2023.
  • Over 3 years, Tax Provisions stood at $990000.0 in 2022, then skyrocketed by 41.41% to $1.4 million in 2023, then plummeted by 97.21% to $39000.0 in 2024.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $39000.0, $1.4 million, and $990000.0 for Q2 2024, Q4 2023, and Q4 2022 respectively.